Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

GSK application to expand use of Nucala for COPD accepted for review by EMA

GSK cancer drug JEMPERLI gets speedy USFDA approval

Ruchika Sharma25 April 2021 9:30 AM IST

London: GlaxoSmithKline plc has recently announced that the US Food and Drug Administration (USFDA) has approved JEMPERLI (dostarlimab-gxly), a...

Amid India's request to lift ban, US defends restrictions on export of Covid vaccine raw materials

Ruchika Sharma25 April 2021 9:00 AM IST

Washington: Defending U.S.' restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India's...

US CDC recommends resuming Johnson & Johnson COVID-19 vaccine

Ruchika Sharma24 April 2021 6:33 PM IST

Washington: Centers for Disease Control and Prevention (CDC) vaccine advisory committee on Friday (local time) recommended resuming the use of Johnson...

Zydus Cadila gets DCGI nod to moderate Covid-19 drug Virafin

Ruchika Sharma24 April 2021 1:06 PM IST

Virafin will be available on the prescription of medical specialist for use in hospital/ institutional setup.

USFDA flags problems at factory making Johnson and Johnson COVID vaccine

Ruchika Sharma24 April 2021 12:00 PM IST

New Delhi: The Baltimore factory hired to help make Johnson & Johnson's Covid-19 vaccine was dirty, didn't follow proper manufacturing procedures...

Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg

Alembic Pharma gets USFDA nod for depression drug Doxepin Hydrochloride Capsules

Ruchika Sharma24 April 2021 11:00 AM IST

Vadodara: Drugmaker, Alembic Pharmaceuticals Limited, has recently announced the company has received final approval from the US Food & Drug...

Cadila Healthcare eyes doubling Covid-19 vaccine capacity amid record India surge: Bloomberg

Ruchika Sharma23 April 2021 3:38 PM IST

New Delhi: Indian drugmaker Cadila Healthcare Ltd., which expects regulatory approval for its vaccine against Covid-19 by June, will potentially ramp...

Pfizer, Moderna to get COVID vaccine ingredient from VAV Lifesciences

Ruchika Sharma23 April 2021 2:01 PM IST

Phospholipids are crucial biomolecules used in manufacturing of mRNA-based Covid-19 vaccines.

Gland Pharma bags USFDA nod for generic Foscarnet Sodium Injection

Ruchika Sharma23 April 2021 12:59 PM IST

Foscarnet Sodium Injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome...

Russian COVID Vaccine: India to get Sputnik V by may end, says Dr Reddys

Ruchika Sharma23 April 2021 12:06 PM IST

New Delhi: India will start receiving Russia's Sputnik V Covid-19 vaccine by end-May, its local distributor Dr. Reddy's Laboratories told Reuters on...

Zydus Cadila bags USFDA nod for anti-arrhythmic drug Propafenone Hydrochloride ER Capsules

Ruchika Sharma23 April 2021 10:00 AM IST

Ahmedabad: Drug major, Zydus Cadila, has recently announced that the company has received final approval from the United States Food and Drug...

Per dose of Covishield to cost Rs 400 for states, Rs 600 for private hospitals: Serum Institute

Ruchika Sharma22 April 2021 12:00 PM IST

New Delhi: Serum Institute of India''s Covishield vaccine will cost private hospitals Rs 600 per dose and state governments Rs 400, a rate which will...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok